San Francisco, CA, United States of America

Gene Michal

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 259(Granted Patents)


Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gene Michal in Biomedical Sciences

Introduction

Gene Michal, an esteemed inventor based in San Francisco, CA, is celebrated for his significant contributions to biomedical engineering. With a remarkable portfolio of 14 patents, Michal stands out in the field for his innovative approaches to developing advanced biomaterials that have the potential to revolutionize medical treatments.

Latest Patents

Among his latest inventions, Gene Michal has developed hydrogel bioscaffoldings designed for application in cardiac care. These bioscaffoldings, which are formed of hydrogels that are crosslinked in situ within the compromised myocardium, utilize Michael's addition reaction or disulfide bonds established through oxidative processes. The bioscaffoldings prominently feature hyaluronan along with a selection of other components such as collagen, collagen-laminin, poly-1-lysine, and fibrin. Notably, they may contain alginate and are engineered to incorporate biofunctional groups like angiogenic factors and stem cell homing factors, enhancing their utility in tissue regeneration when combined with stem cells and microspheres filled with homing factors.

Another significant patent involves the creation of self-reinforcing composite biomatrix compositions using silk proteins. These innovative compositions can be manufactured and utilized for various medical applications, and they typically comprise two functionalized polymers and silk protein. The inclusion of cell types and growth factors enables advanced therapeutic potential. The capabilities of this invention extend to delivery via dual-lumen injection devices for treatment in situ, in vivo, and ex vivo.

Career Highlights

Gene Michal's career has been marked by notable positions at reputable organizations such as Abbott Cardiovascular Systems, Inc. and Advanced Cardiovascular Systems, Inc. His work within these companies has allowed him to influence the development of cutting-edge technologies in cardiovascular care, positioning him as a key figure in his field.

Collaborations

Throughout his career, Gene has collaborated with esteemed colleagues, including John Joseph Stankus and Shubhayu Basu. These partnerships have undoubtedly enriched his work, facilitating the exchange of ideas and leading to groundbreaking developments in biomedical devices and methodologies.

Conclusion

Gene Michal's innovative spirit and dedication to advancing biomedical technology are evident through his numerous patents and collaborative efforts. His inventions are paving the way for enhanced treatments in cardiac care and highlight the importance of innovation in the medical field. As a leading inventor, Michal continues to contribute to the integration of science and technology, making a lasting impact on healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…